On January 13, 2026, Enspire DBS Therapy, Inc. announced that it raised $10.3 million in a Series B1 financing led by Genesys Capital. It also saw participation from existing investors Cleveland Clinic and JobsOhio Ventures.
Genesys Capital invests in and builds companies in the high-growth sectors of biotechnology, pharmaceuticals and medical technology.
Osler, Hoskin & Harcourt LLP advised Genesys Capital with a team consisting of Chad Bayne, Gary Marshall, Sahil Chopra and Nik Popovski (Emerging and High Growth Companies).
Key Contact
Partner, Emerging and High Growth Companies, Toronto
Team
Partner, Emerging and High Growth Companies, Toronto
Associate, Emerging and High Growth Companies, Toronto
Associate, Emerging and High Growth Companies, Toronto
